1. Home
  2. VIR vs NHC Comparison

VIR vs NHC Comparison

Compare VIR & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • NHC
  • Stock Information
  • Founded
  • VIR 2016
  • NHC 1971
  • Country
  • VIR United States
  • NHC United States
  • Employees
  • VIR N/A
  • NHC N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • NHC Hospital/Nursing Management
  • Sector
  • VIR Health Care
  • NHC Health Care
  • Exchange
  • VIR Nasdaq
  • NHC Nasdaq
  • Market Cap
  • VIR 1.4B
  • NHC 1.7B
  • IPO Year
  • VIR 2019
  • NHC N/A
  • Fundamental
  • Price
  • VIR $9.70
  • NHC $101.65
  • Analyst Decision
  • VIR Buy
  • NHC
  • Analyst Count
  • VIR 6
  • NHC 0
  • Target Price
  • VIR $34.83
  • NHC N/A
  • AVG Volume (30 Days)
  • VIR 3.8M
  • NHC 60.9K
  • Earning Date
  • VIR 02-20-2025
  • NHC 02-14-2025
  • Dividend Yield
  • VIR N/A
  • NHC 2.42%
  • EPS Growth
  • VIR N/A
  • NHC 174.32
  • EPS
  • VIR N/A
  • NHC 7.98
  • Revenue
  • VIR $78,618,000.00
  • NHC $1,223,271,000.00
  • Revenue This Year
  • VIR N/A
  • NHC N/A
  • Revenue Next Year
  • VIR N/A
  • NHC N/A
  • P/E Ratio
  • VIR N/A
  • NHC $12.65
  • Revenue Growth
  • VIR N/A
  • NHC 10.74
  • 52 Week Low
  • VIR $6.56
  • NHC $87.03
  • 52 Week High
  • VIR $14.45
  • NHC $138.49
  • Technical
  • Relative Strength Index (RSI)
  • VIR 52.17
  • NHC 43.48
  • Support Level
  • VIR $10.09
  • NHC $94.76
  • Resistance Level
  • VIR $11.39
  • NHC $103.41
  • Average True Range (ATR)
  • VIR 0.71
  • NHC 2.47
  • MACD
  • VIR -0.11
  • NHC 1.20
  • Stochastic Oscillator
  • VIR 16.57
  • NHC 69.94

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About NHC National HealthCare Corporation

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

Share on Social Networks: